WIN Member Seminar Series: Melanie Campbell Group

Monday, June 29, 2020 1:00 pm - 2:00 pm EDT (GMT -04:00)

The Waterloo Institute for Nanotechnology (WIN) is comprized of many talented faculty members, students and researchers from various backgrounds of study. We wanted to showcase their incredible work through our Member Seminar Series! Each month a professor and 2 of their researchers will present their research to our community. This series is an opportunity for our WIN community to come together, learn about ongoing research and potentially foster new partnerships between students, faculty and labs.

This seminar is being delivered via WebEx. If you do not already have the WebEx app or browser installed, you will be prompted to do so to join the meeting.

To pre-register and receive a calendar invitation

If you would like a calendar invitation to this seminar, please email with your RSVP.


"Using the retina to look into the brain in Alzheimer’s disease”- Professor Melanie Campbell


Professor Melanie Campbell

The retina forms as an outpouching of the brain and, like the brain, contains neural cells. Thus, we expected and have confirmed that deposits of amyloid protein form in the retinal neural cell layers, analogous to their formation in the brain early in the Alzheimer’s disease (AD) process. Our patented technique, using polarized light without a dye, can identify presumed amyloid deposits with 100% sensitivity in retinas of those with a diagnosis of AD. In addition, the number of deposits predicts the severity of amyloid pathology in the brain and the overall severity of the disease pathology. This technique holds great promise as an earlier, less invasive, readily available diagnostic which will enable less expensive testing of promising treatments and earlier, more accurate disease diagnosis.

“Multifractal analysis for differentiating retinal amyloid deposits associated with different pathologies” - Peter Neathway


Peter Neathway

Amyloid-laden deposits with intrinsic polarization signals form in the retina in association with Alzheimer’s disease. Similar deposits also seem to form in association with other ocular conditions, like age-related macular degeneration, and in association with various brain pathologies. Linear retardance is the polarization signal that provides the strongest contrast between deposits and retinal surround. Multifractal analysis (MFA) is a means of representing the complexity/texture of a set as a spectrum and has been used in a variety of biomedical imaging applications. This work demonstrated that MFA of linear retardance maps could statistically differentiate between deposits associated with various pathologies, as could polarization signals. These results indicate the potential of MFA and polarimetry for diagnostic purposes.

“Predicting the positivity for thioflavin fluorescence of retinal deposits found in association with Alzheimer’s disease by their polarimetric properties” - Yunyi Qiu


Yunyi Qiu

Alzheimer’s disease (AD) is a neurodegenerative disease which leads to cognitive impairment and ultimately death. Amyloid deposits composed of misfolded amyloid-β protein serve as the hallmarks for AD. Thioflavin is a fluorescent marker for amyloid, including amyloid-β. Here, we present three machine learning methods with the aim of predicting when retinal deposits found in association with AD are positive in thioflavin fluorescence from their interaction with polarized light, without using a dye. Two oversampling strategies were applied to overcome data imbalance. This research demonstrated that thioflavin positivity of retinal amyloid deposits can be predicted from their polarimetry images. These results indicate polarimetry is a promising dye free method of detecting amyloid deposits in ex vivo retinal tissue.